跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
詹 超舜
助理教授
,
心臟血管內科
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北醫學大學臺北心臟醫學研究中心
https://orcid.org/0000-0002-9307-4468
電子郵件
chan_chao_shun
yahoo.com
tw
h-index
151
引文
8
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2013
2024
每年研究成果
概覽
指紋
網路
專案
(4)
研究成果
(20)
類似的個人檔案
(6)
指紋
查看啟用 Chao-Shun Chan 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Infarction
18%
All Cause Mortality
11%
Antiarrhythmic Agent
6%
Arrhythmogenesis
100%
Atrial Fibrillation
58%
Biological Marker
18%
Bruton Tyrosine Kinase Inhibitor
18%
Calcium Ion
24%
Cardiomyopathy
18%
Chelerythrine
18%
Chloroquine
18%
Chronic Obstructive Lung Disease
18%
Cohort Study
6%
Dysplasia
16%
End Stage Renal Disease
18%
Fibrosis
6%
Glucagon Like Peptide 1 [7-36] Amide
15%
Glucagon Like Peptide 1 Receptor Agonist
15%
Glucagon-Like Peptide 1 Receptor
18%
H-89
8%
Heart Arrhythmia
18%
Heart Failure
41%
Heart Failure with Reduced Ejection Fraction
18%
Heart Infarction
9%
Heart Right Ventricle Dysplasia
37%
Heart Ventricle Arrhythmia
33%
Heart Ventricle Fibrillation
7%
Heart Ventricle Tachycardia
33%
Hydrogen Sulfide
18%
Ibrutinib
18%
In-Stent Restenosis
18%
Ivabradine
18%
Leporidae
13%
Long QT Syndrome
18%
microRNA
18%
Mortality Rate
6%
N [2 [[N [3 (4 Chlorophenyl) 2 Propenyl] N Methylamino]methyl]phenyl] N (2 Hydroxyethyl) 4 Methoxybenzenesulfonamide
9%
Persistent Atrial Fibrillation
18%
Polyvinylchloride
8%
Prematurity
6%
Prevalence
7%
Protein Kinase C
18%
Rabbit Model
20%
Ranolazine
10%
Recurrence Risk
5%
Recurrent Disease
25%
Rottlerin
9%
Sodium Ion
15%
Tachycardia
26%
Valsartan/Sacubitril
18%
Medicine and Dentistry
Arrhythmogenesis
22%
Arrhythmogenic Right Ventricular Dysplasia
37%
Arterial Stiffness
18%
Atrial Fibrillation
67%
Atrial Flutter
18%
Biological Marker
20%
Bruton Tyrosine Kinase Inhibitor
18%
Cardiac Dysrhythmia
18%
Cardiomyopathy
18%
Catheter Ablation
50%
Catheter Ablation
8%
Computer Assisted Tomography
18%
Coronary Artery
37%
Dysplasia
16%
ECG Abnormality
18%
Electrocardiogram
28%
Electrography
6%
Framingham Risk Score
18%
Hazard Ratio
6%
Heart Failure
18%
Heart Ventricle Arrhythmia
33%
Ibrutinib
18%
In-Stent Restenosis
18%
Intracellular Calcium
7%
Isotopes of Calcium
21%
Left Atrium
25%
microRNA
18%
microRNA 24
5%
Noncontact Mapping
18%
Persistent Atrial Fibrillation
18%
Polyvinylchloride
8%
Prematurity
6%
Pulmonary Vein
56%
Recurrent Disease
27%
Repolarization
18%
Right Ventricular Outflow Tract Tachycardia
18%
Sinoatrial Node
18%
Superior Vena Cava
18%
Ventricular Outflow Tract
31%
Ventricular Tachycardia
12%
Biochemistry, Genetics and Molecular Biology
Action Potential Duration
9%
Adrenergic Receptor
9%
Afterdepolarization
23%
AMP-activated Protein Kinase
18%
Atrial Fibrillation
94%
Atrial Flutter
18%
Clinical Study
6%
Cyclic Nucleotide
9%
Dysplasia
18%
Elastase
9%
Electric Activity
29%
Electric Conductivity
9%
Electric Potential
14%
Electrocardiogram
22%
Glibenclamide
6%
H-89
9%
Haemophilia
6%
Hyperlipidemia
6%
Hypothermia
18%
Leporidae
7%
Leukocyte
9%
Microelectrode
14%
MicroRNA
18%
MiR-132
6%
Nerve Block
9%
Potassium Channel
12%
Premature Atrial Contraction
9%
Rabbit Model
23%
Tachyarrhythmia
28%
Tachycardia
28%
Transcription Regulation
6%
Western Blot
9%
